Bolt Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.
CEOWilliam P. Quinn
CEOWilliam P. Quinn
Employees52
Employees52
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2015
Founded2015
Employees52
Employees52
BOLT Key Statistics
Market cap10.79M
Market cap10.79M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume18.84K
Average volume18.84K
High today$5.88
High today$5.88
Low today$5.52
Low today$5.52
Open price$5.88
Open price$5.88
Volume24.77K
Volume24.77K
52 Week high$15.60
52 Week high$15.60
52 Week low$5.20
52 Week low$5.20
People also own
Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.